Rituxan (rituximab) - Roche
bortezomib - Generic mfg.
Neupogen (filgrastim) - Kyowa Kirin, Amgen
vincristine - Generic mfg.
Valcyte (valganciclovir) - Roche, Tanabe Pharma
zidovudine - Generic mfg.
sirolimus - Generic mfg.
etoposide IV - Generic mfg.
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity (clinicaltrials.gov) - Oct 22, 2026 - P2 | N=75 | Active, not recruiting | Sponsor: National Cancer Institute (NCI) | Trial completion date: Oct 2026 ➔ Oct 2028 | Trial primary completion date: Oct 2026 ➔ Oct 2028 
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease • Oncology • Rare Diseases
http://clinicaltrials.gov/ct2/show/NCT00092222
 
Oct 22, 2026
 
Prev Next